Efficacy of pretreatment with remimazolam on prevention of propofol-induced injection pain in patients undergoing gastroscopy

医学 异丙酚 麻醉 生理盐水 入射(几何) 不利影响 临床终点 随机对照试验 外科 内科学 物理 光学
作者
Ruimei Yuan,Jing Wen,Qingfei Xing,Chao Lei,Chunhai Hu,Jie Ren,Fanjun Meng
出处
期刊:Scientific Reports [Springer Nature]
卷期号:13 (1) 被引量:5
标识
DOI:10.1038/s41598-023-47151-3
摘要

Abstract To evaluate the efficacy of remimazolam pretreatment in preventing propofol-induced injection pain (PIP) in patients undergoing gastroscopy. One hundred and forty patients (ASA I–II, aged 18–65 years, BMI 18–28 kg/m 2 ) who were to undergo gastroscopy were randomized into either a saline group (group S) or a remimazolam group (group R) (n = 70 for each) on a computer-generated random number basis. The patients in group S received normal saline (0.1 ml/kg) and those in group R were administered remimazolam (0.1 mg/kg) via intravenous infusion for 60 s. 30 s after the injection of normal saline or remimazolam, patients received intravenously propofol (0.5 ml/s) until loss of consciousness. A different anesthesiologist who was unaware of the pretreatment was responsible for maintaining the outcome. The primary endpoint of our study was the incidence of PIP, which was measured using a 4-point scale. Secondary endpoints include the intensity of PIP, vital signs, characteristics of surgery and recovery, and adverse events. The incidence of PIP was significantly lower in group R than in group S (13 vs 51%, p < 0.001), and a lower percentage of patients presented with moderate PIP (3 vs 20%, p < 0.001). Moreover, lower consumption of propofol, shorter recovery time, and greater patient satisfaction were observed in group R than in group S. Pretreatment with remimazolam can effectively reduce the incidence and intensity of PIP in gastroscopy and shorten the recovery time without severe adverse effects. Clinical Trials Registration: Trial Registration: Chinese Clinical Trial Registry (identifier: ChiCTR2200063793). Registry time: 16/09/2022. Registry name: Efficacy of Pre-Treatment with Remimazolam on Prevention of Propofol-Induced Injection Pain in Patients Undergoing Gastroscopy. The date of patient enrollment began from 2022-9-17 to 2022-10-10. The link to the registration: https://www.chictr.org.cn/showproj.html?proj=176004 .
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
一见你就笑完成签到,获得积分10
刚刚
Lucas应助九块钱采纳,获得10
1秒前
苹果易真完成签到,获得积分10
1秒前
1秒前
想多睡会儿完成签到,获得积分10
2秒前
谢陈完成签到 ,获得积分10
2秒前
LiZheng完成签到,获得积分10
3秒前
3秒前
3秒前
完美的越彬关注了科研通微信公众号
4秒前
充电宝应助老实面包采纳,获得10
4秒前
4秒前
标致玉米完成签到,获得积分10
4秒前
ppat5012完成签到 ,获得积分10
4秒前
尹尹尹发布了新的文献求助10
4秒前
书俭完成签到,获得积分10
5秒前
机智宛秋完成签到,获得积分10
5秒前
NexusExplorer应助科研通管家采纳,获得10
5秒前
5秒前
特大包包完成签到,获得积分10
5秒前
5秒前
85搏一博应助科研通管家采纳,获得10
6秒前
丘比特应助科研通管家采纳,获得10
6秒前
orixero应助科研通管家采纳,获得10
6秒前
脂蛋白抗原完成签到,获得积分10
6秒前
6秒前
85搏一博应助科研通管家采纳,获得10
6秒前
去有风的地方完成签到,获得积分10
6秒前
小二郎应助科研通管家采纳,获得10
6秒前
共享精神应助科研通管家采纳,获得10
6秒前
英俊谷秋发布了新的文献求助10
6秒前
桶装乐事完成签到,获得积分10
6秒前
赘婿应助科研通管家采纳,获得10
6秒前
NexusExplorer应助科研通管家采纳,获得10
6秒前
方赫然应助科研通管家采纳,获得10
6秒前
慕青应助科研通管家采纳,获得10
6秒前
赘婿应助科研通管家采纳,获得10
7秒前
方赫然应助科研通管家采纳,获得10
7秒前
Owen应助科研通管家采纳,获得10
7秒前
7秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
MATLAB在传热学例题中的应用 500
Geochemistry, 2nd Edition 地球化学经典教科书第二版,不要epub版本 431
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3303465
求助须知:如何正确求助?哪些是违规求助? 2937777
关于积分的说明 8483915
捐赠科研通 2611774
什么是DOI,文献DOI怎么找? 1426140
科研通“疑难数据库(出版商)”最低求助积分说明 662539
邀请新用户注册赠送积分活动 647059